Case #576

Merge of DRG 292 and DRG 293

Added by Anja Fagervold over 2 years ago. Updated over 2 years ago.

Status:RejectedStart date:2018-01-24
Priority:NormalSpent time:-
Assignee:Anja Fagervold
Target version:Target version 2019
Initiator:Norway Target year:2019
Case type:Major Owner / responsible:Nordic Casemix Centre
MDC:MDC10 Old forum status:
Target Grouper:COMMON


DRG 292 "Op ved sykdommer i HDG 10 ITAD m/bk" and DRG 293 "Op ved sykdommer i HDG 10 ITAD u/bk" has very low volume. We therefore suggest to merge these DRGs.

Both DRGs has very low volume. In 2017 DRG 292 had 45 cases and DRG 293 had 24 cases. The volume in 2016 og 2015 was about the same as in 2017.

The weight for DRG 292 is 4,865 and for DRG 293 it is 2,434. Despite the difference in weight we still suggest to merge because of the low volume.

We suggest to delete DRG 292, and include these cases in DRG 293. DRG 293 will be renamed to "Op ved sykdommer i HDG 10 ITAD". We already have DRG 293O "Op ved sykdommer i HDG 10 ITAD, dagkirurgisk behandling".

DRG change
Delete DRG 292, rename DRG 293.

Technical change
drglogic: 490D100010 will be mapped to DRG 293 instead of DRG 292, and compl 1 is removed.
drgnames: DRG 292 deleted, rename DRG 293
See appendix with technical changes for details.

Technical changes_case 576.xls (105 KB) Anja Fagervold, 2018-01-24 14:27

Technical changes case #576.xlsx (21.6 KB) Martti Virtanen, 2018-03-01 14:59


#2 Updated by Kristiina Kahur over 2 years ago

Finnish National DRG-Centre 25-1-2018

There is every year (during last three years) around 70 cases in both DRGs and the cost difference between DRG 292 and 293 depending on CC is remarkable (ca 30%). Therefore we do not see this change necessary for Finland and the cost data do not support it either.

#3 Updated by Mats Fernström over 2 years ago

Mats Fernström, NPK, Sweden 2018-02-22 (NPK ID C735)
DRG 292 corresponds to the Swedish DRG L39E ’Andra operationer för endokrin, nutrit & metab sjukdomar, ej komplicerat and DRG 293 corresponds to DRG L39C ’Andra operationer för endokrin, nutrit & metab sjukdomar, komplicerat’. During the last two years we had an average of 234 cases in DRG L39C and 107 cases in DRG L39E in our national patient register. The average costs were 94 445 SEK in DRG L39C and 64 026 SEK in DRG L39E.
The big difference in cost is against merging and the number of cases is enough to have two groups. Thus we do not want this change in Sweden.

#4 Updated by Martti Virtanen over 2 years ago

2018-03-01 Martti Virtanen
There seems to be no agreement for this change. However, if Norway wishes to do the change it can be done for Norway only.
The technical change table includes the necessary change which is only to remove the rule for DRG 293X.
It mus remain for other countries.
The remaining DRG should be 293 rather than 292 but this is not important.

#5 Updated by Anja Fagervold over 2 years ago

We withdraw the case.

#6 Updated by Martti Virtanen over 2 years ago

  • Status changed from Active to Rejected

2017-03-09 Martti Virtanen
Rejected because of withrawal

Also available in: Atom PDF